Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium.

Choroidal neovascularization in age-related macular degeneration is a frequent and poorly treatable cause of vision loss in elderly Caucasians. This choroidal neovascularization has been associated with the expression of vascular endothelial growth factor (VEGF). In current animal models choroidal neovascularization is induced by subretinal injection of growth factors or vectors encoding growth factors such as VEGF, or by disruption of the Bruch's membrane/retinal pigment epithelium complex with laser treatment. We wished to establish a transgenic murine model of age-related macular degeneration, in which the overexpression of VEGF by the retinal pigment epithelium induces choroidal neovascularization. A construct consisting of a tissue-specific murine retinal pigment epithelium promoter (RPE(65) promoter) coupled to murine VEGF(164) cDNA with a rabbit beta-globin-3' UTR was introduced into the genome of albino mice. Transgene mRNA was expressed in the retinal pigment epithelium at all ages peaking at 4 months. The expression of VEGF protein was increased in both the retinal pigment epithelium and choroid. An increase of intravascular adherent leukocytes and vessel leakage was observed. Histopathology revealed intrachoroidal neovascularization that did not penetrate through an intact Bruch's membrane. These results support the hypothesis that additional insults to the integrity of Bruch's membrane are required to induce growth of choroidal vessels into the subretinal space as seen in age-related macular degeneration. This model may be useful to screen for inhibitors of choroidal vessel growth.

[1]  J. Grunwald,et al.  Changes in Choriocapillaris and Retinal Pigment Epithelium ( RPE ) in Age-Related Macular Degeneration , 1999 .

[2]  R. D'Amato,et al.  Regulation of Vascular Endothelial Growth Factor Expression by Insulin-Like Growth Factor I , 1997, Diabetes.

[3]  M. P. Hartmann,et al.  Basic fibroblast growth factor experimentally induced choroidal angiogenesis in the minipig. , 1994, Current eye research.

[4]  A. Kvanta.  Expression and regulation of vascular endothelial growth factor in choroidal fibroblasts. , 1995, Current eye research.

[5]  Y. Li,et al.  Vascular endothelial growth factor regulates both apoptosis and angiogenesis of choriocapillaris endothelial cells. , 2000, Microvascular research.

[6]  R. Nagel,et al.  Retinal and choroidal neovascularization in a transgenic mouse model of sickle cell disease. , 1994, The American journal of pathology.

[7]  I J Constable,et al.  Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization. , 2000, The American journal of pathology.

[8]  T. Veikkola,et al.  VEGFs, receptors and angiogenesis. , 1999, Seminars in cancer biology.

[9]  G. Neufeld,et al.  The VEGF Splice Variants: Properties, Receptors, and Usage for the Treatment of Ischemic Diseases , 2000, Herz.

[10]  K Miyamoto,et al.  Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1). , 2000, The American journal of pathology.

[11]  G. Lutty,et al.  Vascular endothelial growth factor and vascular permeability changes in human diabetic retinopathy. , 1997, Investigative ophthalmology & visual science.

[12]  S. Yu,et al.  The Upstream Region of the Rpe65 Gene Confers Retinal Pigment Epithelium-specific Expression in Vivo and in Vitro and Contains Critical Octamer and E-box Binding Sites* , 2000, The Journal of Biological Chemistry.

[13]  K. Nakagawa,et al.  The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[14]  J. Folkman,et al.  Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells. , 1993, Biochemical and biophysical research communications.

[15]  H. Kaplan,et al.  Distribution of growth factors in subfoveal neovascular membranes in age-related macular degeneration and presumed ocular histoplasmosis syndrome. , 1995, American journal of ophthalmology.

[16]  R. Frank,et al.  Growth factor localization in choroidal neovascular membranes of age-related macular degeneration. , 1994, Investigative ophthalmology & visual science.

[17]  H. Grossniklaus,et al.  Pathologic features of surgically excised subretinal neovascular membranes in age-related macular degeneration. , 1991, American journal of ophthalmology.

[18]  D. McDonald,et al.  Angiogenesis in mice with chronic airway inflammation: strain-dependent differences. , 1998, The American journal of pathology.

[19]  P. Henkind,et al.  Ultrastructure of Bruch's membrane after krypton laser photocoagulation. I. Breakdown of Bruch's membrane. , 1986, Archives of ophthalmology.

[20]  E. Voest,et al.  Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. , 1996, The Journal of clinical investigation.

[21]  M. Klagsbrun,et al.  Vascular endothelial growth factor and its receptors. , 1996, Cytokine & growth factor reviews.

[22]  H. Dvorak,et al.  A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. , 1986, Cancer research.

[23]  P. Campochiaro,et al.  Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. , 1997, The American journal of pathology.

[24]  R. Jain,et al.  During angiogenesis, vascular endothelial growth factor regulate natural killer cell adhesion to tumor endothelium , 1996, Nature Medicine.

[25]  Ivana K. Kim,et al.  Constitutive expression of VEGF, VEGFR-1, and VEGFR-2 in normal eyes. , 1999, Investigative ophthalmology & visual science.

[26]  S. Seregard,et al.  Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. , 1996, Investigative ophthalmology & visual science.

[27]  Y Ikada,et al.  A new model of subretinal neovascularization in the rabbit. , 1995, Investigative ophthalmology & visual science.

[28]  C. Puliafito,et al.  A new model of experimental choroidal neovascularization in the rat. , 1989, Archives of ophthalmology.

[29]  D. McDonald,et al.  Permeability-related changes revealed at endothelial cell borders in inflamed venules by lectin binding. , 1996, The American journal of physiology.

[30]  P. D. de Jong,et al.  Increased expression of angiogenic growth factors in age-related maculopathy , 1997, The British journal of ophthalmology.

[31]  H. Dvorak,et al.  Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. , 1983, Science.

[32]  K Miyamoto,et al.  VEGF increases retinal vascular ICAM-1 expression in vivo. , 1999, Investigative ophthalmology & visual science.

[33]  D. Hinton,et al.  Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. , 1996, Investigative ophthalmology & visual science.

[34]  A Kijlstra,et al.  Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation. , 1999, The American journal of pathology.

[35]  Thomas N. Sato,et al.  Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. , 1999, Science.

[36]  D. Goeddel,et al.  Vascular endothelial growth factor is a secreted angiogenic mitogen. , 1989, Science.

[37]  F. Kruse,et al.  In vivo significance of ICAM-1--dependent leukocyte adhesion in early corneal angiogenesis. , 1999, Investigative ophthalmology & visual science.

[38]  D. Dimitrov,et al.  Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. , 1992, Biochemical and biophysical research communications.

[39]  R. Frank,et al.  A model of subretinal neovascularization in the pigmented rat. , 1989, Current eye research.

[40]  P. Campochiaro,et al.  Intravitreal Sustained Release of VEGF Causes Retinal Neovascularization in Rabbits and Breakdown of the Blood– Retinal Barrier in Rabbits and Primates , 1997 .

[41]  Joan W. Miller,et al.  Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate. , 1996, Archives of ophthalmology.

[42]  S Miglior,et al.  Subretinal neovascularization after naphthalene damage to the rabbit retina. , 1994, Investigative ophthalmology & visual science.

[43]  D. S. Mcleod,et al.  A new technique for visualization of the human retinal vasculature. , 1992, Archives of ophthalmology.

[44]  H Ueno,et al.  The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. , 1992, Science.

[45]  G. Palade,et al.  Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. , 1995, Journal of cell science.

[46]  J. Winer,et al.  The vascular endothelial growth factor family of polypeptides , 1991, Journal of cellular biochemistry.

[47]  Joan W. Miller,et al.  Cloning and mRNA expression of vascular endothelial growth factor in ischemic retinas of Macaca fascicularis. , 1996, Investigative ophthalmology & visual science.

[48]  D. Eliott,et al.  Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes. , 1996, American journal of ophthalmology.

[49]  R K Jain,et al.  Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. , 1998, The Journal of investigative dermatology.

[50]  E S Gragoudas,et al.  Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. , 1996, Ophthalmology.

[51]  W. Heriot,et al.  Ultrastructure of Bruch's membrane after krypton laser photocoagulation. II. Repair of Bruch's membrane and the role of macrophages. , 1986, Archives of ophthalmology.